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Introduction
The sharing of needles and syringes whileinjecting illicit drugs means that hepatitis C
virus (HCV) is the most common infectious disease
to affect people who inject drugs. Parenteral
exposure is the major risk factor for HCV infection
in Australia (1), North America (2), the United
Kingdom (3), Europe (4), and many developing
countries including Vietnam (5) and China (6).
Blood-borne viruses like HCV are public health
problems of global significance with more than 2%
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Transitions to Injecting and Risk of Hepatitis C
Transmission among Ethnic Vietnamese Heroin Smokers
in Melbourne, Australia
Background and Aims: To examine factors associated with transition from non-injecting to injecting routes of drug
administration and testing antibody positive to hepatitis C virus (HCV) among ethnic Vietnamese heroin users in
Melbourne, Australia.
Methods: In a cross-sectional convenience survey, sample recruited by peer-workers using snowball sampling
technique with a finger prick blood collection. Two-hundred ethnic Vietnamese heroin users were recruited and
interviews conducted mainly in Footscray, an area of high ethnic Vietnamese residency with a prominent street based
drug market. A structured questionnaire was administered. Measures included patterns of drug use, transition from
smoking to injecting and vice versa, injection related risk behaviours and HCV sero-status.
Results: Ninety-three percent of the sample commenced drug use by non-injecting routes of administration. More than
a half had made the transition from smoking to injecting and almost two thirds of participants had ever injected. The
factors associated with making this transition included being male and a longer duration of use. Prevalence of exposure
to HCV among injectors was over 50%. Factors associated with being HCV positive were longer duration of injecting,
sharing injecting equipment and being older.
Conclusions: Smoking heroin is a common route of drug administration among heroin users of Vietnamese ethnicity in
this study. The transition from smoking to injecting was very common in the sample. The need for targeted harm
reduction initiatives is indicated, and these must take into account patterns of heroin use as well as the social context
of drug use if we are to work effectively with heroin users of Vietnamese ethnicity.
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of people worldwide thought to be infected with
HCV (7). In Australia, injecting drug use accounts
for at least 80 percent of total cases with most
previous prevalence studies finding that between 50
and 80 percent of IDU are believed to have been
exposed to HCV (1, 8). In 2003, it was estimated
that more than 240,000 people have been infected
with HCV in Australia (9) and among these; an
estimated 134,000 have developed HCV chronic
infection. While less than 500 cases of newly
acquired HCV infection are notified each year in
Australia, an estimated 16,000 new infections occur
annually (10), and 90% of these are attributed to
people who report injecting drugs (11).
HCV infection frequently occurs early in a drug
user career, even before the user seeks help or advice
for any drug related problem (12-14). Among
injecting drug users who do not share syringes, some
HCV infections may be attributed to the sharing of
other injecting equipment such as cookers/
cottons/filters (13-15). HCV is not classified as a
sexually transmitted infection and cases of sexual
transmission are thought to be extremely rare (16,
17). Heroin can be administered through non-
injected routes or can be injected (usually
intravenously). Non-injecting routes include
intranasal use (sniffing), chasing the dragon
(inhaling vaporized heroin after heating it on tinfoil)
and smoking heroin in cigarettes and/or mixed with
marijuana (snow-cone). Smoking heroin has been
increasingly evident in Australia with a study in
South West Sydney reporting heroin smoking as a
common route of drug administration among
young Indochinese heroin users with more than a
half of the sample commencing heroin use by
smoking (18). Of these, 34% made a transition to
injecting.
When non-injecting drug users make the
transition to injecting, the risk of acquiring blood-
borne diseases increases and given this there
continues to be considerable public health interest
in understanding more clearly why some non-
injection drug users make the transition and
whether limiting this is both feasible and practical
(19). With this in mind we designed a study to
examine the patterns of drug use associated with the
transition to injecting among heroin smokers and to
determine rates of HCV exposure for both smokers
and injectors of heroin.
Materials and Methods
Study design
The study ran from late 1999 to mid 2000 and
was based in Footscray, Melbourne. It was a peer
focussed quantitative study with ethnic Vietnamese
peer interviewers being recruited primarily through
the established networks of the study investigators.
The selection process for peer interviewers included
an assessment and interview by the first two authors
(PH & JK). Selection was based on previously
determined criteria, including experience of heroin
use, proficiency in English language, good
communication skills, access to other ethnic
Vietnamese heroin users, interest in drug use
research and commitment to the project. Eleven
people were invited to join an intensive training
program which was mandatory for all potential peer
interviewers. The median age of the interviewers was
20 years (range: 18-38). Two of the peer interviewers
were female. After 20 hours of training, the peer
interviewers were directed to contact other heroin
users through chain referral within their own
personal and social networks and to invite them to
participate in the study. Both heroin smokers and
injectors were eligible to participate in the study as
long as they were ethnic Vietnamese (as determined
by language spoken, country of birth or parent's
birth and self-identified ethnicity) and had used
heroin at least once in the last six months. Informed
consent was obtained prior to the interview.
Data and specimens collection
The study instrument was a structured
questionnaire available in both Vietnamese and
English. The 80 questions covering basic
demographics; drug use history, transitions between
different routes of administration were extensively
trialled by the peer workers within the group and
piloted with eleven potential participants outside
the group prior to implementation. The
questionnaire was translated from English into
Vietnamese by a qualified translator and back
translated with support from the peer interviewers
to ensure equivalency. It was available in both
languages. To ensure optimal reliability of the self-
reported information several strategies were used:
use of peers as interviewers, conducting one-to-one
interviews in a relaxed and private setting and
production of an information sheet for respondents.
Peer interviewers were also encouraged to explain in
some detail the nature of the research and the need
for accurate information. Capillary blood specimens
were collected by peer workers on blotting paper by
finger prick with single-use lancets. Antibody testing
for hepatitis C was performed using a modified
third generation enzyme immunoassay (Abbott
HCV EIA 3.0, Chicago, USA). Specimens were
considered positive for HCV antibody if the optical
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density to cut-off ratio was greater than or equal to
1.35 on initial and subsequent testing.
Data analysis
Data were initially entered into an SPSS database
and double-checked. STATA software (version 7.0)
was used to analyse data. Percentages were used for
categorical variables; means were used for normally
distributed continuous variables, medians were
presented instead of means if continuous variables
were skew. Univariate analyses were used for major
variables of interest identified from literature and
ongoing ethnographic research. Chi-squared test
and unadjusted odds ratios were used for categorical
variables. Student's t-test and Mann-Whitney test
were used for normally distributed and skewed data,
respectively. The 0.05 probability level was adopted
for all tests. A logistic regression model was used to
determine associations with the transition from
smoking to injecting, and HCV seropositivity.
Variables were selected into the model based on
prior knowledge and the significance of odds ratio in
univariate analysis.
Results
Two-hundred interviews with heroin users of
Vietnamese ethnicity across the western suburbs of
Melbourne were conducted by peer interviewers in
English (n=173) and Vietnamese (n=27). A majority
of the interviews (66%) were conducted at the shop
front office of the project. The remaining interviews
were conducted in homes, cafes and other public
spaces chosen by the interviewers and respondents.
Female heroin users in this sample were younger on
average than their male counterparts (19.8 vs. 24.5,
P<0.0001) and made up 20% (n=40) of
participants. The age of participants ranged from 15
to 49, with a mean of 22.7 years. Seventy three
percent of participants in this study were under 25
year of age.
Heroin use
The average age of first heroin use was 17 years
(range: 11 to 24 years). Most participants (92%)
started using heroin in Australia and most began by
non-injecting routes of administration, with
smoking or burning being the most prominent
(83%). At the time of interview, the participants had
used heroin for an average duration of 5.5 years
(range from less than 1 year to 19 years). Most
participants (61.5%) had ever injected heroin prior
to interview and heroin was the first injected drug
for the entire sample. Among the injectors in the
sample 95% first injected in Australia the others
having done so in Vietnam or a refugee camp on
their way to Australia. The average age of
participants at first injection of heroin was 19 years
(range: 13 to 26 years). For injecting heroin users,
the average duration of injecting was 4.5 years
(range from less than 1 year to 10 years).
Most participants (95%, n=191) had used heroin
either on the street or other public places in the six
months prior to interview. Of these, 34.5% (n=66)
used heroin on the street daily. Public toilets and
cars were the main places nominated by participants
as the places where they used. About half of the
respondents to the study reported having used in a
public setting even when they did not purchase their
heroin from the street market. Male heroin users in
this sample were over seven times more likely to
have ever injected heroin than the female users
interviewed (P<0.0001). Injecting heroin was also
associated with age and duration of use. Participants
who were 20 years or older were four times more
likely have injected than people younger than 20
years of age (P<0.001). The injectors in the sample
had used heroin for longer on average than their
non-injecting counterparts (6.9 years vs. 3.2 years;
P<0.001).
Transitions from smoking to injecting heroin
More than a half of the participants (53%) who
started heroin use by non-injecting routes of
administration had switched to injecting prior to
being interviewed. The main reasons for this
transition cited by participants included:
cheaper/stronger method (43%), curiosity (15%),
for the rush (33%) and peer pressure (6%). Females
were significantly less likely to have ever made the
transition from smoking to injecting; only six (15%)
made the transition compared to 96 males (60%)
(OR=0.12; 95% CI: 0.04-0.31). There was no
significant difference in the length of time in
making this transition between the male and female
heroin users in the study.
The average time between initiating heroin use
and switching to injecting was 2.7 years with a range
from less than 1 year to 10 years. Participants who
smoked heroin for 5 years or more were 4.8 times
more likely to have switched to injecting relative to
those who had smoked for a shorter period of time
(95% CI: 2.45-9.43; P<0.001). Those who used
heroin on the street and in public places on a daily
basis were also more likely to make the transition
from smoking to injecting relative to those who used
less frequently or never in public places (OR=3.26;
95% CI: 1.34-5.91; P<0.0001). Twenty one per
cent of the injectors in our study had made a reverse
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transition from injecting to smoking at some stage
in the previous 6 months.
Hepatitis C
About half of the sample (104 respondents)
reported they had been previously tested for HCV.
Of these, 28 respondents (27%) claimed a previous
positive HCV antibody test result five of whom were
actually antibody negative when their sample was
tested. Seventy respondents previously tested
reported being HCV negative nineteen of whom
tested HCV antibody positive. Only 6 respondents
(6%) did not know or remember their HCV result
and 3 of them were HCV antibody positive. Over
95% of HCV positive cases were among the
injectors. The overall rate of HCV for the sample
was 37% (95% CI: 29.61-44.28). However, when
looking only at the injectors in the sample, the HCV
antibody rate was 56% (95% CI: 45.22-64.41).
Only four respondents who reported never injecting
tested HCV antibody positive.
Being HCV antibody positive was strongly
associated with duration of use. As duration of use
increased so too did the likelihood of an HCV
antibody positive test result. The injectors in the
sample who had used for more than 5 years were
4.54 times (95% CI: 1.79-11.84; P<0.001) more
likely to be HCV antibody positive relative to IDUs
who had used for less than five years. HCV
seropositivity was strongly associated with age. The
risk of being HCV antibody positive among IDU
participants who were 20 years or older was 11.84
times greater than those IDUs aged under 20. HCV
infection was strongly associated with being a
current injector of heroin. Respondents who tested
positive to hepatitis C antibodies were 34 times
more likely to have ever injected heroin.
Respondents who reported having a previous HCV
test were also more likely to be current injectors.
Similarly, HCV serostatus was strongly associated
with duration of injecting. Those who had been
injecting for more than 5 years were 8.64 times
more likely to be HCV antibody positive relative to
those who had been injecting for less than 5 years.
The sharing of injecting equipment was associated
with increased risk of being hepatitis C positive.
Fifty-two per cent of injectors reported re-using
syringes and needles (usually their own needle or
syringe) at some stage in their injecting careers. The
proportion of injectors who reported ever shared
syringes and needles was 18%. Injectors who shared
needles and syringes in the last six months were 3.48
times more likely to test positive to hepatitis C
antibodies when compared with those who did not
report such sharing (95% CI: 0.98-15.48; P<0.01).
Discussion
Although the majority of participants began their
heroin using careers by smoking, more than half had
switched to injecting by the time of their interview
in this study. Risk factors for this transition
identified by this study were a longer duration of
using heroin, using in public places and being male.
The overall rate of HCV in this sample was 37%,
but this proportion rose to 56% amongst those who
had ever injected. Similar to other research on
hepatitis C exposure for participants in this study
HCV seropositivity was associated with increased
age and duration of use, injecting heroin and
duration of injecting and the sharing of injecting
equipment (2, 12).
The reported reasons for making the transition
from smoking to injecting in this study are similar to
others in the literature. The perceived benefits of
injecting over other routes in cost-effectiveness and
strength of drug "rush" have been reported in other
similar studies (18, 20). The reasons why ethnic
Vietnamese female heroin users in the sample were
much less likely to make the transition to injecting
cannot be explained by the results of study itself.
Overseas studies have found that the stigma
associated with injecting lowers the risk of transition
to injecting (21). The social stigma and shame
associated with injecting may well contribute to the
reluctance of ethnic Vietnamese female heroin users
to take up injecting. The younger age of the female
participants in the sample (19.5 years vs. 23.5 years;
P<0.001) may also be a confounding factor in their
preference for non-injecting methods of
administration. The design and implementation of
longitudinal studies may help to answer this
question in the longer term.
One fifth of the injectors in this study had made
a reverse transition from injecting to smoking at
some stage in the 6 months prior to interview. This
result was in contrast with an earlier Sydney based
study which reported that none of the Indochinese
participants (mainly ethnic Vietnamese) had made a
reverse transition from injecting to smoking and
only 3% of Caucasian respondents had ever done so
(18). This change is a positive observation and the
reasons behind reverse transitions warrant further
investigation. The results of our study showed that
the risk of exposure to HCV was not significantly
different among those who had switched from
smoking to injecting or those who had made a
reverse transition. Given the cross-sectional design
of the study, it is impossible to identify when HCV
infection occurred in the drug user's career.
Nonetheless almost a third (14 participants) of those
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who had been using for two years or less were
already HCV anti-body positive. Studies have
shown that many drug users are infected soon after
their initiation to injecting (13, 20) and that this is a
crucial time for developing HCV prevention
interventions.
This study reports a lower prevalence of HCV
among the injectors in the sample in comparison
with previous studies conducted with this
population in Melbourne (22). Subsequent studies
with this population group in Melbourne have
continued to report positive HCV antibody status at
around 80% (23, 24). The explanation we offer for
this discrepancy is that many of the study
participants were young (55% of the sample was
aged 21 years or younger) and had used for only
short periods of time compared to participants in
other studies. Furthermore, unlike these studies, in
which only injectors were tested for exposure to
HCV, this sample included also exclusive heroin
smokers. Sharing injecting equipment, and in
particular needles and syringes, remains the highest
concern with regards to HCV transmission and
infection. Among this sample the risk of HCV
seropositivity was more than three times greater
amongst those who reported needle sharing than
those who did not. The proportion of injectors who
shared syringes and needles (18%) in the previous
month was comparable with previous studies of
ethnic Vietnamese drug users (22%) (13) and the
17% of people who reported re-suing a needle or
syringe after someone else had used it in a national
study of attendees to needle and syringe programs in
Australia (25).
Some evidence has been produced of other
possible routes of HCV transmission amongst
Vietnamese-born people who do not report a history
of drug use (26) but these explanations among this
sample are unlikely, in most part due to the young
age of participants and the fact that many of them
would not have experienced the exposure risks
reported above (common cultural and medical
practices) which tended to occur in Vietnam. A
substantial majority of participants had used heroin
on the streets or in public places. The public use of
heroin has created a great deal of concern not only
from local traders and shoppers in the local
neighborhood of Footscray. This high profile use of
heroin has created an environment for increased
police attention in these street based markets. The
public health risks for individual heroin users as well
as to the law enforcement personnel are well
documented (27, 28) and important to consider when
determining the best strategies for managing street
based drug markets.
Conclusions
Our study found that risk behaviours including
re-using and sharing injecting equipment among
this group were common. Our study indicates the
need for targeted, research and evidence based
initiatives which take into account patterns of drug
use as well as social and cultural characteristics and
contexts of use by ethnic Vietnamese heroin users.
The specific challenges of street based drug scenes
and the specific needs of users of Vietnamese
ethnicity are not easily accommodated by
mainstream services or traditional forms of service
delivery. The development of locally based primary
health care centres goes some way towards helping
alleviate the harms encountered by many of the
most problematic illicit heroin users we interviewed.
A continued commitment to the development of
services which account for these challenges is an
important component of effective harm reduction
based service provision.
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